Abiopharma

Samenvatting: Philips en Imricor lanceren een MR-laboratoriumoplossing voor hartingrepen en breiden daarmee hun langdurige samenwerking uit

General Announcement: Net Asset Value ("NAV") per Unit

General Announcement: Net Asset Value ("NAV") per Unit

General Announcement: Net Asset Value ("NAV") per Unit

General Announcement: Net Asset Value ("NAV") per Unit

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Deficient and Delinquent.

General Announcement: Net Asset Value ("NAV") per Unit

General Announcement: Net Asset Value ("NAV") per Unit

Resumen: Philips e Imricor presentan una solución de RM intervencionista cardíaca y amplían su colaboración

General Announcement: Net Asset Value ("NAV") per Unit

General Announcement: Net Asset Value ("NAV") per Unit

HURLSTON MICHAEL E. 🟡 adjusted position in 7.4K shares of Lumentum Holdings Inc. (LITE) at $958.66 Transaction Date: Aug 25, 2026 | Filing ID: 000017

HURLSTON MICHAEL E. 🟢 acquired 66.8K shares of Lumentum Holdings Inc. (LITE) Transaction Date: Aug 17, 2026 | Filing ID: 000016

Wupen Yuen 🟡 adjusted position in 4.6K shares of Lumentum Holdings Inc. (LITE) at $958.66 Transaction Date: Aug 25, 2026 | Filing ID: 000007

Retort Vincent 🔴 sold 38.7K shares of Lumentum Holdings Inc. (LITE) at $860.05 ($33.0M) Transaction Date: Aug 25, 2026 | Filing ID: 000008